Sabuya, Jose L.

HRN: 19-02-99  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2023
CEFTRIAXONE 1G (VIAL)
10/21/2023
10/28/2023
IV
2g
Daily
Indirect InguinalHernia, Right, Irreducible; Hydrocele, Right; S/P Herniorrhaphy (March 2020, MRH)
Checking Final Appropriateness 
10/21/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/21/2023
10/28/2023
IV
500mg
Every 8 Hours
Indirect InguinalHernia, Right, Irreducible; Hydrocele, Right; S/P Herniorrhaphy (March 2020, MRH)
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: